Stock 4173 ARICH ENTERPRISE CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Arich Enterprise Co., Ltd.

Equities

4173

TW0004173000

Pharmaceuticals

End-of-day quote Taipei Exchange
Other stock markets
 18:00:00 2024-05-30 EDT 		5-day change 1st Jan Change
21.5 TWD +0.23% Intraday chart for Arich Enterprise Co., Ltd. +0.23% -2.05%
05-14 Arich Enterprise Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
03-20 Arich Enterprise Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 690.9 893.7 1,872 1,342 1,443 1,637
Enterprise Value (EV) 1 1,711 1,541 1,734 912.9 816.8 1,411
P/E ratio 13.8 x 14.7 x 34.9 x 24.3 x 23 x 21.5 x
Yield 6.7% - 2.23% 2.78% 3.36% 4.19%
Capitalization / Revenue 0.53 x 0.8 x 1.5 x 1.42 x 1.42 x 1.44 x
EV / Revenue 1.31 x 1.39 x 1.39 x 0.97 x 0.8 x 1.24 x
EV / EBITDA 33.9 x 22.7 x 34.8 x 15.7 x 11.9 x 15.6 x
EV / FCF -6.43 x 2.93 x 4.06 x 2.18 x 10.8 x -3.99 x
FCF Yield -15.6% 34.1% 24.6% 45.8% 9.24% -25.1%
Price to Book 0.57 x 0.71 x 1.05 x 0.74 x 0.77 x 0.81 x
Nbr of stocks (in thousands) 44,574 44,574 74,574 74,574 74,574 74,574
Reference price 2 15.50 20.05 25.10 18.00 19.35 21.95
Announcement Date 19-03-28 20-03-06 21-03-29 22-03-25 23-03-25 24-03-20
1TWD in Million2TWD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 1,302 1,112 1,251 945.7 1,018 1,140
EBITDA 1 50.46 67.94 49.82 58 68.84 90.27
EBIT 1 46.41 65.52 48.33 54.43 64.12 81.9
Operating Margin 3.57% 5.89% 3.86% 5.76% 6.3% 7.18%
Earnings before Tax (EBT) 1 46.34 74.65 62.72 68.12 79.5 95.5
Net income 1 50.28 60.63 47.25 55.3 62.62 76.53
Net margin 3.86% 5.45% 3.78% 5.85% 6.15% 6.71%
EPS 2 1.120 1.360 0.7200 0.7400 0.8397 1.020
Free Cash Flow 1 -266.2 525.4 427 418.2 75.49 -353.6
FCF margin -20.45% 47.24% 34.13% 44.22% 7.42% -31.02%
FCF Conversion (EBITDA) - 773.33% 857.17% 721% 109.67% -
FCF Conversion (Net income) - 866.58% 903.81% 756.2% 120.56% -
Dividend per Share 2 1.039 - 0.5602 0.5000 0.6500 0.9197
Announcement Date 19-03-28 20-03-06 21-03-29 22-03-25 23-03-25 24-03-20
1TWD in Million2TWD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 1,020 647 - - - -
Net Cash position 1 - - 138 429 626 226
Leverage (Debt/EBITDA) 20.21 x 9.53 x - - - -
Free Cash Flow 1 -266 525 427 418 75.5 -354
ROE (net income / shareholders' equity) 4.44% 4.91% 3.11% 3.07% 3.38% 3.92%
ROA (Net income/ Total Assets) 0.58% 0.97% 0.78% 0.81% 0.85% 0.97%
Assets 1 8,703 6,270 6,027 6,858 7,368 7,900
Book Value Per Share 2 27.10 28.30 23.90 24.40 25.20 27.10
Cash Flow per Share 2 1.800 3.760 5.520 7.780 9.260 7.430
Capex 1 0.3 3.08 3.71 12.8 22.4 17.3
Capex / Sales 0.02% 0.28% 0.3% 1.36% 2.2% 1.52%
Announcement Date 19-03-28 20-03-06 21-03-29 22-03-25 23-03-25 24-03-20
1TWD in Million2TWD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Pharmaceuticals Wholesale

1st Jan change Capi.
ARICH ENTERPRISE CO., LTD. Stock Arich Enterprise Co., Ltd.
-2.05% 49.3M
MCKESSON CORPORATION Stock McKesson Corporation
+23.03% 74.04B
CARDINAL HEALTH, INC. Stock Cardinal Health, Inc.
-1.52% 24.18B
SINOPHARM GROUP CO. LTD. Stock Sinopharm Group Co. Ltd.
+3.67% 8.46B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD Stock Shanghai Pharmaceuticals Holding Co., Ltd
+8.55% 8.34B
HUADONG MEDICINE CO., LTD Stock Huadong Medicine Co., Ltd
-23.71% 7.64B
H. LUNDBECK A/S Stock H. Lundbeck A/S
+15.20% 5.33B
EBOS GROUP LIMITED Stock EBOS Group Limited
-6.90% 3.92B
GALENICA AG Stock Galenica AG
+2.68% 4.12B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD Stock Jointown Pharmaceutical Group Co., Ltd
+5.56% 3.89B
Pharmaceuticals Wholesale
  1. Stock Market
  2. Equities
  3. 4173 Stock
  4. Financials Arich Enterprise Co., Ltd.